Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
Bibliographic Data
| ID | 14905774 |
|---|---|
| Authors | Matthew J Akiyama (0000-0003-4290-3083, Albert Einstein College of Medicine, corresponding author), Lindsey R Riback (0000-0001-8805-270X, Albert Einstein College of Medicine), Mercy Nyakowa (Ministry of Health), Helgar Musyoki (0000-0002-0972-6065, Ministry of Health), John A Lizcano, John Lizcano (0000-0003-4470-2189, Yale University), Abbe Muller (0000-0002-2650-8318, Yale University), Chenshu Zhang (0000-0002-3233-3905, Albert Einstein College of Medicine), John Geoffrey Walker (0000-0002-9732-5738, University of Bristol), Josephine G Walker, Jack Stone (0000-0002-4584-0068, University of Bristol), Peter Vickerman (0000-0002-8291-5890, University of Bristol), Peter Cherutich (0000-0002-0019-0372, Ministry of Health), Ann Kurth (0000-0003-2300-6723, Yale University), Ann E Kurth |
| Year | 2023 |
| Volume | 113 |
| Pages | 103959 |
| Publication date | 2023-03-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2023.103959 |
| PMID | 36758335 |
| OpenAlex | W4319335988 |
| Language | EN |
| Citations received | 1 |
| References cited | 51 |
Directly Observed Therapy · Family medicine · Hepatitis C · Hepatitis C virus · Human immunodeficiency virus (HIV · Ledipasvir · Logistic regression · Multivariate analysis · Odds · Sofosbuvir · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Internal Medicine · Virology
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya
Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya
Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine
Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination
Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh
| Citations per year | 1 |
|---|---|
| Citation span | 2025 - 2025 (1) |
| Highly cited | No |